<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Minato</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Nirasawa</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sato</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Yamaguchi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Hoshizaki</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Inagaki</surname>
    <given-names>T.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction</article-title>. 
  <source>Nat. Commun.</source>
  <volume>11</volume> (
  <issue>1</issue>), 
  <fpage>1058</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41467-020-14867-z</pub-id>
  <pub-id pub-id-type="pmid">32103002</pub-id>
 </mixed-citation>
</ref>
